Table 1.
|
Morphologic features
|
Tissue characterization
|
||
LGE
|
Mapping
|
ECV
|
||
Athlete’s heart | Balanced increase in wall thickness and cavity size | Absent or in RV insertion points | Normal or decreased T1 | Normal or decreased |
Hypertrophic cardiomyopathy (sarcomeric) | Typically asymmetric LVH, with septal predominance | Mid-mural, patchy, affecting most hypertrophied segments; transmural in advanced stages | Increased native T1, regardless of LGE presence, reflecting interstitial fibrosis | Increased ECV attributed to fibrosis |
Amyloidosis | Symmetric or asymmetric LVH | Subendocardial, global, diffuse; transmural in advanced stages. LGE reflects infiltration, not fibrosis; abnormal gadolinium kinetics | Marked increase in native T1 value (AL > ATTR) due to protein accumulation | Markedly increased ECV reflecting protein accumulation |
Fabry disease | Concentric LVH, prominent papillary muscles, RV hypertrophy | Mid-mural, basal inferolateral segment | Decreased native T1 values (lipid storage); pseudonormalization in advance stages due to fibrosis. Elevated T2 levels due to inflammation | Normal ECV |
ECV: Extracellular volume; LGE: Late gadolinium enhancement; LVH: Left ventricular hypertrophy; RV: Right ventricle.